226 related articles for article (PubMed ID: 23200092)
21. Interpreting coronary artery disease GWAS results: A functional genomics approach assessing biological significance.
Hartmann K; Seweryn M; Sadee W
PLoS One; 2022; 17(2):e0244904. PubMed ID: 35192625
[TBL] [Abstract][Full Text] [Related]
22. Genetic study of complex diseases in the post-GWAS era.
Huang Q
J Genet Genomics; 2015 Mar; 42(3):87-98. PubMed ID: 25819085
[TBL] [Abstract][Full Text] [Related]
23. Statistical and Functional Studies Identify Epistasis of Cardiovascular Risk Genomic Variants From Genome-Wide Association Studies.
Li Y; Cho H; Wang F; Canela-Xandri O; Luo C; Rawlik K; Archacki S; Xu C; Tenesa A; Chen Q; Wang QK
J Am Heart Assoc; 2020 Apr; 9(7):e014146. PubMed ID: 32237974
[TBL] [Abstract][Full Text] [Related]
24. Rare variants and cardiovascular disease.
Wain LV
Brief Funct Genomics; 2014 Sep; 13(5):384-91. PubMed ID: 24771349
[TBL] [Abstract][Full Text] [Related]
25. Genetics 100 for cardiologists: basics of genome-wide association studies.
Dubé JB; Hegele RA
Can J Cardiol; 2013 Jan; 29(1):10-7. PubMed ID: 23200095
[TBL] [Abstract][Full Text] [Related]
26. Pro: Genome-wide association studies (GWAS) in asthma.
Weiss ST; Silverman EK
Am J Respir Crit Care Med; 2011 Sep; 184(6):631-3. PubMed ID: 21920925
[No Abstract] [Full Text] [Related]
27. From Genotype to Phenotype: A Primer on the Functional Follow-up of Genome-Wide Association Studies in Cardiovascular Disease.
Lin J; Musunuru K
Circ Genom Precis Med; 2018 Feb; 11(2):. PubMed ID: 29915816
[TBL] [Abstract][Full Text] [Related]
28. The contribution of non-coding regulatory elements to cardiovascular disease.
Villar D; Frost S; Deloukas P; Tinker A
Open Biol; 2020 Jul; 10(7):200088. PubMed ID: 32603637
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide association studies of cancer: principles and potential utility.
Stadler ZK; Gallagher DJ; Thom P; Offit K
Oncology (Williston Park); 2010 Jun; 24(7):629-37. PubMed ID: 20669800
[TBL] [Abstract][Full Text] [Related]
30. Unraveling Difficult Answers: From Genotype to Phenotype in Coronary Artery Disease.
Magdy T; Burridge PW
Cell Stem Cell; 2019 Feb; 24(2):203-205. PubMed ID: 30735646
[TBL] [Abstract][Full Text] [Related]
31. Challenges and progress in interpretation of non-coding genetic variants associated with human disease.
Zhu Y; Tazearslan C; Suh Y
Exp Biol Med (Maywood); 2017 Jul; 242(13):1325-1334. PubMed ID: 28581336
[TBL] [Abstract][Full Text] [Related]
32. Applying in silico integrative genomics to genetic studies of human disease.
Saccone SF
Int Rev Neurobiol; 2012; 103():133-56. PubMed ID: 23195124
[TBL] [Abstract][Full Text] [Related]
33. Genetic Susceptibility Contributing to Periodontal and Cardiovascular Disease.
Aarabi G; Zeller T; Seedorf H; Reissmann DR; Heydecke G; Schaefer AS; Seedorf U
J Dent Res; 2017 Jun; 96(6):610-617. PubMed ID: 28530468
[TBL] [Abstract][Full Text] [Related]
34. Exploring the genetic basis of coronary artery disease using functional genomics.
López Rodríguez M; Arasu UT; Kaikkonen MU
Atherosclerosis; 2023 Jun; 374():87-98. PubMed ID: 36801133
[TBL] [Abstract][Full Text] [Related]
35. The miRNA targetome of coronary artery disease is perturbed by functional polymorphisms identified and prioritized by in-depth bioinformatics analyses exploiting genome-wide association studies.
Bastami M; Nariman-Saleh-Fam Z; Saadatian Z; Nariman-Saleh-Fam L; Omrani MD; Ghaderian SMH; Masotti A
Gene; 2016 Dec; 594(1):74-81. PubMed ID: 27596011
[TBL] [Abstract][Full Text] [Related]
36. Identifying functional noncoding variants from genome-wide association studies for cardiovascular disease and related traits.
Smith AJ; Humphries SE; Talmud PJ
Curr Opin Lipidol; 2015 Apr; 26(2):120-6. PubMed ID: 25692342
[TBL] [Abstract][Full Text] [Related]
37. Convolutional neural network model to predict causal risk factors that share complex regulatory features.
Lee T; Sung MK; Lee S; Yang W; Oh J; Kim JY; Hwang S; Ban HJ; Choi JK
Nucleic Acids Res; 2019 Dec; 47(22):e146. PubMed ID: 31598692
[TBL] [Abstract][Full Text] [Related]
38. Using DIVAN to assess disease/trait-associated single nucleotide variants in genome-wide scale.
Chen L; Qin ZS
BMC Res Notes; 2017 Oct; 10(1):530. PubMed ID: 29084591
[TBL] [Abstract][Full Text] [Related]
39. Functional annotation of HOT regions in the human genome: implications for human disease and cancer.
Li H; Chen H; Liu F; Ren C; Wang S; Bo X; Shu W
Sci Rep; 2015 Jun; 5():11633. PubMed ID: 26113264
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide genotype-serum proteome mapping provides insights into the cross-ancestry differences in cardiometabolic disease susceptibility.
Xu F; Yu EY; Cai X; Yue L; Jing LP; Liang X; Fu Y; Miao Z; Yang M; Shuai M; Gou W; Xiao C; Xue Z; Xie Y; Li S; Lu S; Shi M; Wang X; Hu W; Langenberg C; Yang J; Chen YM; Guo T; Zheng JS
Nat Commun; 2023 Feb; 14(1):896. PubMed ID: 36797296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
